Back to search
FDAFDA · Food and drugs·Recall number Z-1451-2018

SOMATOM Spirit Intended to produce cross-sections images of the body by computer reconstruction of x-ray transmission data.

Published May 9, 2018 · Recall initiated: February 15, 2018

Summary

FDA records medical device Class II recall Z-1451-2018, published May 9, 2018 and initiated February 15, 2018. Recalling firm: Siemens Medical Solutions USA, Inc; Status: Terminated; Reported quantity: 1301; Lot: (Not supplied). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

to inform customers of possible incorrect tube current calculations by the CARE Dose4D algorithm for head scans based on p.a. (posterior-anterior) or a.p. (anterior-posterior) topograms. Depending on the geometrical shape of the skull bone, it may happen in rare cases that the calculated dose distribution is not appropriate and could lead to unnecessary radiation exposure

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Medical Solutions USA, Inc
Distributor
USA (nationally) Distribution.
Lot
(Not supplied)
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was SOMATOM Spirit Intended to produce cross-sections images of the body by computer reconstruction of x-ray transmission data. recalled?

Yes. FDA published recall Z-1451-2018 on May 9, 2018. Reported hazard: to inform customers of possible incorrect tube current calculations by the CARE Dose4D algorithm for head scans based on p.a. (posterior-anterior) or a.p. (anterior-posterior) topograms. Depending on the geometrical shape of the skull bone, it may happen in rare cases that the calculated dose distribution is not appropriate and could lead to unnecessary radiation exposure

What should I do if I have this product?

Voluntary: Firm initiated · Letter